Slick Woods, born Simone Thomson, has decided to stop her treatment for stage three melanoma, which is an aggressive form of the disease and can be fatal.
Slick Woods, born Simone Thomson, has decided to stop her treatment for stage three melanoma, which is an aggressive form of the disease and can be fatal.
Posted in Melanoma News, Patients, Patient Stories
A test that monitors blood levels of DNA fragments released by dying tumor cells may serve as an accurate early indicator of treatment success in the late stages of one of the most aggressive forms of skin cancer, a new study finds.
Posted in Melanoma News, Health Professionals, Of Interest
Dermoscopy allows for thorough observation of morphologic features not visible to the naked eye in melanoma screening, according to a speaker at the South Beach Symposium Medical Dermatology Summit.
Posted in Melanoma News, Health Professionals, Of Interest
In a new clinical validation study, an international team led by investigators at NYU Langone Health has demonstrated that BRAF gene mutations detected in cell-free circulating tumor DNA (ctDNA) can offer a window into treatment response and potential outcomes in individuals with melanoma.
Posted in Melanoma News, Health Professionals, Of Interest